West Pharma raises annual forecasts
West Pharma shares rise after the company raises its annual forecasts.
Related stories
Ambev earnings above expectations at 0.28 BRL
Ambev (ABEV3) released earnings per share at 0.28 BRL, compared to market expectations of 0.25 BRL.
H impact | EARNINGS | Oct 29, 2026, 06:12 PM UTC
Prysmian earnings above expectations at 1.65 EUR
Prysmian (PRY) released earnings per share at 1.65 EUR, compared to market expectations of 1.48 EUR.
H impact | EARNINGS | Oct 29, 2026, 06:12 PM UTC
Exchange Bank Reports Q3 Net Income of $8.9M, NII Up 8.4%
Unaudited Q3 2026 net income was $8.9 million, compared with $8.6 million a year earlier. Net interest income rose 8.4% to $25.2 million as interest expense declined.
M impact | EARNINGS | Oct 29, 2026, 06:01 PM UTC
Exchange Bank Reports Third-Quarter 2026 Net Income of $8.9 Million
Exchange Bank reported unaudited net income after taxes of $8.9 million for the quarter ended September 30, 2026, and $23.7 million for the nine months ended September 30.
M impact | EARNINGS | Oct 29, 2026, 06:00 PM UTC
Bunge Reports Third-Quarter 2026 Net Sales of $23.8 Billion, EPS of $1.64
Bunge reported third-quarter net income of $318 million, compared with $166 million a year earlier. Diluted EPS was $1.64, up from $0.84.
M impact | EARNINGS | Oct 29, 2026, 05:51 PM UTC
Advantest Shares Rise 6.01% After Annual Outlook Upgrade
Advantest shares closed 6.01% higher at 37,030 on October 29 after the semiconductor-testing equipment maker lifted its annual outlook following first-half results.
M impact | EARNINGS | Oct 29, 2026, 05:51 PM UTC